10 free leads on us
Otsuka
Headquarters
Glattbrugg, Zurich Office
Slough, Berkshire Office
Otsuka Pharmaceutical Companies Europe is a global healthcare company. They researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and nutraceutical products for the maintenance of everyday health. Sales and marketing operations in France, Germany, Italy, the Nordic region, Spain and the UK are supporte d by the regional office of Otsuka Pharmaceutical Europe Ltd. (OPEL), based in London. Otsuka in Europe works as a network' with close collaboration and support between the countries and OPEL.
...Read MoreOtsuka Pharmaceutical Europe Ltd
Otsuka Pharmaceutical Europe Ltd.
Otsuka S.A
Otsuka Holdings Co. Ltd
Otsuka
$185.7 M
550
1998
Name & Title | Social | Contact Info | |
---|---|---|---|
Jason Roy Vice President | Visit Profile | ||
Tsuyoshi Nakamura Vice President, Director - Finance and Accounting | Visit Profile | ||
Tetsuya Tachikawa Senior Operating Officer and Director, Licensing, Global BD | Visit Profile | ||
Rachel Thorpe Associate Director, Foundation Strategy & Operations | Visit Profile | ||
Jean-David Rafizadeh-Kabe Director | Visit Profile | ||
Masako Doi Operating Officer, Director of Research | Visit Profile |
Name & Title | Social | Contact Info | |
---|---|---|---|
Erich Mendoza Clinician | Visit Profile | ||
Parimal Patel Pharmacy Technician | Visit Profile | ||
Chandrakant Tank Filling Machione Operator | Visit Profile | ||
John Donne Clinical Sales Specialist | Visit Profile | ||
Ashish Patel Pharmacist | Visit Profile | ||
Natalia Lukaszewicz Specialty Representative - CNS | Visit Profile | ||
Rachel Thorpe Associate Director, Foundation Strategy & Operations | Visit Profile |
Here's a list of some of the top trending technologies and APIs used by Otsuka.
(3 Technologies)
(2 Technologies)
(2 Technologies)
(2 Technologies)
(2 Technologies)
Company | Employees | Revenue | Top technologies |
---|---|---|---|
Konami | 5,057 | $2.1 B | |
Otsuka Pharmaceutical Co. | 1,336 | $385.6 M | |
Simon Pearce | 316 | $59.7 M | |
HIPRA | 2,500 | $8.7 M | |
Terumo Europe | 1,416 | $478 M |